Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study.
Three ubiquitous and well-studied natural products derived from plants can protect the skin against gamma radiation during radiotherapy, according to new research.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival.
New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs currently used to treat rheumatoid arthritis.
For a rare form of cancer called thymoma, researchers have discovered a single gene defining the difference between a fast-growing tumor requiring aggressive treatment and a slow-growing tumor that does not require extensive therapy.
Researchers have discovered more than 40 genes that predict the level of aggressiveness of melanoma and that distinguish it from other cancers with a poor prognosis.
HIV-infected people with early stage cancer are two to four times more likely to go untreated for their cancer compared to uninfected patients with cancer, according to a new, large retrospective study.
A study of people who were adopted identified genetics as the dominant risk factor in familial breast, prostate, and colorectal cancers.
Researchers have developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma.
A less frequent screening schedule would both reduce health care charges and still protect low-risk childhood cancer survivors from heart ailments caused by drug therapy, according to recently published findings.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|